First Time Loading...

Curaleaf Holdings Inc
TSX:CURA

Watchlist Manager
Curaleaf Holdings Inc Logo
Curaleaf Holdings Inc
TSX:CURA
Watchlist
Price: 6.78 CAD 4.47% Market Closed
Updated: Apr 27, 2024
Section:
 

Wall Street
Price Targets

CURA Price Targets Summary
Curaleaf Holdings Inc

Wall Street analysts forecast CURA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CURA is 9.79 CAD with a low forecast of 6.57 CAD and a high forecast of 19.22 CAD.

CURA Lowest Forecast
Wall Street Target
6.57 CAD
3% Downside
CURA Average Forecast
Wall Street Target
9.79 CAD
44% Upside
CURA Highest Forecast
Wall Street Target
19.22 CAD
183% Upside
Lowest
Price Target
6.57 CAD
3% Downside
Average
Price Target
9.79 CAD
44% Upside
Highest
Price Target
19.22 CAD
183% Upside
Curaleaf Holdings Inc Competitors:
Price Targets
V
VRNO
Verano Holdings Corp
149% Upside
H
293480
Hana Pharm Co Ltd
88% Upside
C
CLN
Celon Pharma SA
12% Upside
T
600867
Tonghua Dongbao Pharmaceutical Co Ltd
59% Upside
V
VRNO
Verano Holdings Corp
149% Upside
H
293480
Hana Pharm Co Ltd
88% Upside
C
CLN
Celon Pharma SA
12% Upside
T
600867
Tonghua Dongbao Pharmaceutical Co Ltd
59% Upside
HIKAL
Hikal Ltd
8% Upside
600329
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd
31% Upside
A
AQST
Aquestive Therapeutics Inc
126% Upside
600420
Shanghai Shyndec Pharmaceutical Co Ltd
61% Upside

Revenue
Forecast

Revenue Estimate
Curaleaf Holdings Inc

The compound annual growth rate of Curaleaf Holdings Inc's revenue for the next 3 years is 15%.

N/A
Past Growth
15%
Estimated Growth
Estimates Accuracy
-5%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Curaleaf Holdings Inc

The compound annual growth rate of Curaleaf Holdings Inc's operating income for the next 3 years is 112%.

N/A
Past Growth
112%
Estimated Growth
Estimates Accuracy
-50%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Curaleaf Holdings Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
40%
Average Beat
What are analyst estimates?

See Also

Summary
CURA intrinsic value, competitors valuation, and company profile.
DCF Valuation
CURA stock valuation using Discount Cash Flow valuation method.
Relative Valuation
CURA stock valuation using valuation multiples.
Wall Street Estimates
CURA price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
CURA stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CURA's stock price target?
Price Target
9.79 CAD

According to Wall Street analysts, the average 1-year price target for CURA is 9.79 CAD with a low forecast of 6.57 CAD and a high forecast of 19.22 CAD.

What is Curaleaf Holdings Inc's Revenue forecast?
Projected CAGR
15%

The compound annual growth rate of Curaleaf Holdings Inc's revenue for the next 3 years is 15%.

What is Curaleaf Holdings Inc's Operating Income forecast?
Projected CAGR
112%

The compound annual growth rate of Curaleaf Holdings Inc's operating income for the next 3 years is 112%.

ALPHA SPREAD
Join more than 131,900+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.